RGX-104

· Inspirna, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGX-104, covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer [Phase 1]